MLYS logo

Mineralys Therapeutics, Inc. (MLYS)

Profile

Full Name

Mineralys Therapeutics, Inc.

Ticker

NASDAQ: MLYS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 10, 2023

Indexes

Not included

Website

https://mineralystx.com

Employees

51

Key Details

Price

$37.10(-0.16%)

Market cap

$2.88B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.66(-83.92% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.10
    MLYS price is $37.10

    30-Day Relative Volume

    0.62
    MLYS 30-day relative volume is 0.62

    Price Performance

    Price Most recent change

    -0.16%
    MLYS price was down -0.16% on Sep 12, 2025

    Price YTD change

    +201.38%
    MLYS price is up +201.38% since January 1st

    Price 1-year change

    +220.1%
    MLYS price is up +220.1% year-on-year

    Price 3-year change

    -
    MLYS price 3-year change is unknown

    Price Range

    Price All-time high

    $39.20
    MLYS price is currently -5.36% below its historical high of $39.20

    Price 3-year low

    $5.85
    MLYS price is currently +534.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.88B
    MLYS market capitalization is $2.88 billion

    Market cap 3-year change

    -
    MLYS market capitalization 3-year change is unknown

    Market cap All-time high

    $2.99B
    MLYS market capitalization is currently -3.79% below its historical high of $2.99 billion

    Market cap sector rank

    84.52%
    MLYS market capitalization is higher than 84.52% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +55.99%
    MLYS shares outstanding is up +55.99% year-on-year

    Shares Outstanding 3-Year Change

    +89.86%
    MLYS shares outstanding is up +89.86% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.53
    MLYS beta is 0.53

    200-day SMA

    $14.19
    MLYS price is currently +161.37% above its 200-day simple moving average

    50-day SMA

    $17.90
    MLYS price is currently +107.22% above its 50-day simple moving average

    RSI

    86.54
    MLYS 14-day relative strength index is 86.54

    Volume

    0.62
    MLYS 30-day relative volume is 0.62

    ATR

    $2.30
    MLYS average true range is $2.30

    10-day Historical Volatility

    424.58%
    MLYS 10-day historical volatility is 424.58%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    MLYS annual revenue is $0.00

    Revenue Analysts estimate

    -
    MLYS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    MLYS annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.75%
    MLYS annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$3.66
    MLYS annual earnings per share is -$3.66

    EPS Analysts estimate

    -$2.72
    MLYS annual earnings per share is currently +34.75% higher than the consensus analysts' forecast

    EPS 1-year change

    -83.92%
    MLYS annual earnings per share is down -83.92% year-on-year

    EPS Sector rank

    25.17%
    MLYS annual earnings per share is higher than 25.17% of companies in Healthcare sector

    Profit

    Gross profit

    -$43.00K
    MLYS annual gross profit is -$43.00 thousand

    Gross margin

    -
    MLYS annual gross profit margin value is unknown

    Operating profit

    -$192.40M
    MLYS annual operating income is -$192.40 million

    Operating margin

    -
    MLYS annual operating profit margin value is unknown

    Net income

    -$177.81M
    MLYS annual net profit is -$177.81 million

    Net margin

    -
    MLYS annual net profit margin value is unknown

    Expenses

    Total expenses

    $192.40M
    MLYS annual total expenses is $192.40 million

    Operating expenses

    $192.40M
    MLYS annual total operating expenses is $192.40 million

    Cost of goods sold

    $43.00K
    MLYS annual cost of goods sold is $43.00 thousand

    Selling, general & administrative expenses

    $23.82M
    MLYS annual SGA is $23.82 million

    Depreciation and amortization

    $43.00K
    MLYS annual depreciation & amortization is $43.00 thousand

    Interest expense

    $0.00
    MLYS annual interest expense is $0.00

    Income tax

    $0.00
    MLYS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$192.40M
    MLYS annual earnings before interest & taxes is -$192.40 million

    EBITDA

    -$192.36M
    MLYS annual EBITDA is -$192.36 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $205.90M
    MLYS annual total assets is $205.90 million

    Non current assets

    $552.00K
    MLYS annual long term assets is $552.00 thousand

    Current assets

    $205.35M
    MLYS annual total current assets is $205.35 million

    Cash and cash equivalents

    $114.09M
    MLYS annual cash & cash equivalents is $114.09 million

    Accounts receivable

    -
    MLYS annual accounts receivable value is unknown

    Inventory

    $0.00
    MLYS annual inventory is $0.00

    Liabilities

    Total liabilities

    $14.65M
    MLYS annual total liabilities is $14.65 million

    Long term liabilities

    $0.00
    MLYS annual total long term liabilities is $0.00

    Current liabilities

    $14.65M
    MLYS annual total current liabilities is $14.65 million

    Accounts payable

    $479.00K
    MLYS annual accounts payable is $479.00 thousand

    Debt

    Total debt

    $0.00
    MLYS annual total debt is $0.00

    Total debt 1-year change

    0%
    MLYS annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    MLYS annual long term debt is $0.00

    Short term debt

    $0.00
    MLYS annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $191.26M
    MLYS annual stockholders equity is $191.26 million

    Book value

    $191.26M
    MLYS annual book value is $191.26 million

    Retained earnings

    -$302.52M
    MLYS annual retained earnings is -$302.52 million

    Working capital

    $190.71M
    MLYS annual working capital is $190.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$166.31M
    MLYS annual cash flow from operations is -$166.31 million

    Cash from operations 1-year change

    -104.89%
    MLYS annual cash flow from operations is down -104.89% year-on-year

    Cash from investing

    $114.96M
    MLYS annual cash flow from investing activities is $114.96 million

    Cash from investing 1-year change

    +171.64%
    MLYS annual cash flow from investing activities is up +171.64% year-on-year

    Cash from financing

    $116.14M
    MLYS annual cash flow from financing activities is $116.14 million

    Cash from financing 1-year change

    -42.86%
    MLYS annual cash flow from financing activities is down -42.86% year-on-year

    CAPEX

    CAPEX

    $96.00K
    MLYS annual capital expenditures is $96.00 thousand

    CAPEX 1-year change

    +100%
    MLYS annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    -$166.41M
    MLYS annual free cash flow is -$166.41 million

    Free cash flow 1-year change

    -105.01%
    MLYS annual free cash flow is down -105.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    MLYS annual gross profit margin value is unknown

    Operating margin

    -
    MLYS annual operating profit margin value is unknown

    Net margin

    -
    MLYS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -77.72%
    MLYS annual return on assets is -77.72%

    ROE

    -82.24%
    MLYS annual return on equity is -82.24%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MLYS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MLYS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    9.18
    MLYS price to book ratio is 9.18

    PB ratio Sector rank

    87.69%
    MLYS price to book ratio is higher than 87.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    MLYS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    MLYS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $2.55B
    MLYS enterprise value is $2.55 billion

    Enterprise value Sector rank

    82.74%
    MLYS enterprise value is higher than 82.74% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.58
    MLYS EV/EBITDA is -12.58

    EV/EBITDA Sector rank

    11.28%
    MLYS EV/EBITDA is higher than 11.28% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    14.02
    MLYS annual current ratio is 14.02

    Quick ratio

    14.02
    MLYS annual quick ratio is 14.02

    Leverage

    Debt to equity

    0.00
    MLYS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    MLYS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    MLYS piotroski f-score value is unknown

    Altman Z-Score

    113.87
    MLYS altman z-score is 113.87

    Analyst ratings

    Recent major analysts updates

    Sep 11, 25 Wells Fargo
    Overweight
    Sep 9, 25 Goldman Sachs
    Buy
    Sep 8, 25 HC Wainwright & Co.
    Buy
    Sep 3, 25 Jefferies
    Hold
    Aug 28, 25 B of A Securities
    Buy
    Aug 13, 25 HC Wainwright & Co.
    Buy
    Jun 17, 25 HC Wainwright & Co.
    Buy
    Jun 11, 25 Jefferies
    Hold
    May 13, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with MLYS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Mineralys Therapeutics, Inc.?
    • Does Mineralys Therapeutics, Inc. pay dividends?
    • What sector is Mineralys Therapeutics, Inc. in?
    • What industry is Mineralys Therapeutics, Inc. in?
    • What country is Mineralys Therapeutics, Inc. based in?
    • When did Mineralys Therapeutics, Inc. go public?
    • Is Mineralys Therapeutics, Inc. in the S&P 500?
    • Is Mineralys Therapeutics, Inc. in the NASDAQ 100?
    • Is Mineralys Therapeutics, Inc. in the Dow Jones?
    • When was Mineralys Therapeutics, Inc.'s last earnings report?
    • When does Mineralys Therapeutics, Inc. report earnings?

    What is the ticker symbol for Mineralys Therapeutics, Inc.?

    The ticker symbol for Mineralys Therapeutics, Inc. is NASDAQ:MLYS

    Does Mineralys Therapeutics, Inc. pay dividends?

    No, Mineralys Therapeutics, Inc. does not pay dividends

    What sector is Mineralys Therapeutics, Inc. in?

    Mineralys Therapeutics, Inc. is in the Healthcare sector

    What industry is Mineralys Therapeutics, Inc. in?

    Mineralys Therapeutics, Inc. is in the Biotechnology industry

    What country is Mineralys Therapeutics, Inc. based in?

    Mineralys Therapeutics, Inc. is headquartered in United States

    When did Mineralys Therapeutics, Inc. go public?

    Mineralys Therapeutics, Inc.'s initial public offering (IPO) was on February 10, 2023

    Is Mineralys Therapeutics, Inc. in the S&P 500?

    No, Mineralys Therapeutics, Inc. is not included in the S&P 500 index

    Is Mineralys Therapeutics, Inc. in the NASDAQ 100?

    No, Mineralys Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Mineralys Therapeutics, Inc. in the Dow Jones?

    No, Mineralys Therapeutics, Inc. is not included in the Dow Jones index

    When was Mineralys Therapeutics, Inc.'s last earnings report?

    Mineralys Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Mineralys Therapeutics, Inc. report earnings?

    The next expected earnings date for Mineralys Therapeutics, Inc. is November 11, 2025
    On this page